Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02119143
Other study ID # 26-151 ex 13/14
Secondary ID
Status Completed
Phase N/A
First received April 17, 2014
Last updated July 29, 2017
Start date April 2014
Est. completion date February 2017

Study information

Verified date July 2017
Source Green Beat
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates the effects of a dietary supplement - a cocktail of vitamins and minerals - on the incidence of common cold in a cohort of middle management employees.The primary outcome is defined as the number of duty days lost due to common cold/flu. Further, immune parameters and markers of redox biology/oxidative stress will be determined. The wellbeing in the cohort will be evaluated via questionnaires.


Description:

randomized, double-blinded, placebo controlled trial 82 Subjects, men and women, 25 - 50 yrs, non-smokers, employees of middle management, 24 weeks of supplementation/placebo, 4 wk wash-out of all supplements and dietetic products, undersupply of fruit, vegetables (< 4 portions/day) and whole grain food (< 5x/wk)


Recruitment information / eligibility

Status Completed
Enrollment 82
Est. completion date February 2017
Est. primary completion date January 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 50 Years
Eligibility Inclusion Criteria:

- pre or peri-menopausal

- non-smokers

- sedentary or moderately trained

- BMI: >20 and < 35kg/m2

- undersupply of fruits, vegetables and whole grain food, fibres

- contraceptives

- wash-out

Exclusion Criteria:

- post-menopausal

- smokers

- trained people

- BMI out of inclusion range

- adequate intake of vegetables, fruits and whole grain food, fibres

- no adherence to wash-out

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
vitamines and minerals
given for 24 weeks, after 4 week wash out of all supplements and dietetic products
placebo
given for 24 weeks, after 4 weeks wash out of all supplements and dietetic products

Locations

Country Name City State
Austria Institute of Pathophysiology and Immunology Graz Styria

Sponsors (2)

Lead Sponsor Collaborator
Green Beat Medical University of Graz

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Other change in redox biology micronutrients may influence redox biology of subjects 24 weeks
Primary Incidence of common cold vitamins and minerals might influence the incidence of common cold in middle aged management employees 24 weeks
Secondary change in immune markers cytokine levels and expression of cytokine receptors in leucocytes may change over time due to micronutrient intervention 24 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03663933 - Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation Phase 2
Completed NCT03563066 - Effect of Benralizumab in Atopic Dermatitis Phase 2
Recruiting NCT04339777 - Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity Phase 2
Not yet recruiting NCT05969821 - Clonal Hematopoiesis of Immunological Significance
Completed NCT02916888 - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists N/A
Completed NCT02527187 - Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa Phase 2
Completed NCT01441076 - Anakinra for Behcet s Disease Phase 1/Phase 2
Completed NCT01472263 - Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Phase 3
Completed NCT03720470 - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy Phase 3
Suspended NCT04642066 - Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters N/A
Completed NCT02294552 - Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT Phase 2
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Completed NCT04103099 - Impact of HLNatural Immune Supplement on Colds N/A
Recruiting NCT03344094 - Mechanism of Action of Ocrelizumab in Multiple Sclerosis N/A
Active, not recruiting NCT05445284 - Group Education Trial to Improve Transition for Parents of Adolescents With T1D N/A
Recruiting NCT06104111 - Epigenetic Memory of Vitamin D Supplementation Phase 1
Not yet recruiting NCT05616117 - Next-generation Effects of Vitamin D Supplementation in Pregnancy
Completed NCT01510626 - Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center Phase 1
Completed NCT01490177 - Single Center Food Allergy Oral Immunotherapy Study Phase 1
Completed NCT03922087 - No-worry Baby Project